Insider Buy/Sell Details for the Biotechnology Industry — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1179)
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
24,362
Price
$33.80
Total Value
$823.44K
Shares Held After
58,382
% of Holdings
29.4%
NewAmsterdam Pharma Co N.V. (NAMS)
Somaiya Mayur Ian — Chief Financial Officer
Shares
15,422
Price
$33.25
Total Value
$512.78K
Shares Held After
82,744
% of Holdings
15.7%
Karyopharm Therapeutics Inc. (KPTI)
Abate Kristin — Chief Accounting Officer
Shares
265
Price
$5.96
Total Value
$1.58K
Shares Held After
22,580
% of Holdings
1.2%
RenovoRx, Inc. (RNXT)
Agah Ramtin — Director
Shares
10,000
Price
$1.00
Total Value
$9.97K
Shares Held After
798,460
% of Holdings
1.3%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
2,000
Price
$3.00
Total Value
$6.00K
Shares Held After
0
% of Holdings
100.0%
Cabaletta Bio, Inc. (CABA)
Chang David J. — Chief Medical Officer
Shares
8,800
Price
$2.26
Total Value
$19.89K
Shares Held After
8,800
% of Holdings
100.0%
Cabaletta Bio, Inc. (CABA)
Binder Gwendolyn — President, Science & Tech.
Shares
11,312
Price
$2.19
Total Value
$24.76K
Shares Held After
31,312
% of Holdings
36.1%
Cabaletta Bio, Inc. (CABA)
Tomasello Shawn — Director
Shares
22,725
Price
$2.21
Total Value
$50.32K
Shares Held After
22,725
% of Holdings
100.0%
Cabaletta Bio, Inc. (CABA)
Gavel Steve — Chief Commercial Officer
Shares
22,170
Price
$2.27
Total Value
$50.22K
Shares Held After
22,170
% of Holdings
100.0%
Cabaletta Bio, Inc. (CABA)
Bollard Catherine — Director
Shares
4,405
Price
$2.27
Total Value
$9.98K
Shares Held After
5,405
% of Holdings
81.5%
Cabaletta Bio, Inc. (CABA)
Nichtberger Steven — Director
Shares
45,000
Price
$2.24
Total Value
$100.78K
Shares Held After
1,031,483
% of Holdings
4.4%
Cabaletta Bio, Inc. (CABA)
Simon Mark — Director
Shares
11,061
Price
$2.28
Total Value
$25.26K
Shares Held After
147,205
% of Holdings
7.5%
Cabaletta Bio, Inc. (CABA)
Gerard Michael — General Counsel
Shares
6,600
Price
$2.27
Total Value
$14.98K
Shares Held After
6,600
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
12,119
Price
$5.05
Total Value
$61.20K
Shares Held After
617,824
% of Holdings
1.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
300
Price
$1.34
Total Value
$402.00
Shares Held After
268,866
% of Holdings
0.1%
ABEONA THERAPEUTICS INC. (ABEO)
Alvino Mark — Director
Shares
13,500
Price
$5.23
Total Value
$70.57K
Shares Held After
48,752
% of Holdings
21.7%
Exicure, Inc. (XCUR)
Exicure HiTron Inc. — 10% Owner
Shares
258,367
Price
$4.50
Total Value
$1.16M
Shares Held After
1,598,947
% of Holdings
13.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
14
Price
$470.75
Total Value
$6.59K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
84
Price
$470.37
Total Value
$39.51K
Shares Held After
14
% of Holdings
85.7%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
451
Price
$469.18
Total Value
$211.60K
Shares Held After
98
% of Holdings
82.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,573
Price
$468.12
Total Value
$736.35K
Shares Held After
549
% of Holdings
74.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
321
Price
$467.09
Total Value
$149.94K
Shares Held After
2,122
% of Holdings
13.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
568
Price
$466.06
Total Value
$264.72K
Shares Held After
2,443
% of Holdings
18.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
966
Price
$465.11
Total Value
$449.30K
Shares Held After
3,011
% of Holdings
24.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,225
Price
$464.06
Total Value
$568.47K
Shares Held After
3,977
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,322
Price
$463.26
Total Value
$612.43K
Shares Held After
5,202
% of Holdings
20.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
271
Price
$461.12
Total Value
$124.96K
Shares Held After
6,524
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
268
Price
$459.86
Total Value
$123.24K
Shares Held After
6,795
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
377
Price
$458.74
Total Value
$172.94K
Shares Held After
7,063
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
372
Price
$457.92
Total Value
$170.35K
Shares Held After
7,440
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
63
Price
$456.87
Total Value
$28.78K
Shares Held After
7,812
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
26
Price
$470.75
Total Value
$12.24K
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
156
Price
$470.37
Total Value
$73.38K
Shares Held After
26
% of Holdings
85.7%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
837
Price
$469.18
Total Value
$392.70K
Shares Held After
182
% of Holdings
82.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
2,922
Price
$468.12
Total Value
$1.37M
Shares Held After
1,019
% of Holdings
74.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
596
Price
$467.09
Total Value
$278.39K
Shares Held After
3,941
% of Holdings
13.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,055
Price
$466.06
Total Value
$491.70K
Shares Held After
4,537
% of Holdings
18.9%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
1,794
Price
$465.11
Total Value
$834.41K
Shares Held After
5,592
% of Holdings
24.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
2,274
Price
$464.06
Total Value
$1.06M
Shares Held After
7,386
% of Holdings
23.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
2,456
Price
$463.26
Total Value
$1.14M
Shares Held After
9,660
% of Holdings
20.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
503
Price
$461.12
Total Value
$231.94K
Shares Held After
12,116
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
498
Price
$459.87
Total Value
$229.01K
Shares Held After
12,619
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
700
Price
$458.74
Total Value
$321.12K
Shares Held After
13,117
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
692
Price
$457.92
Total Value
$316.88K
Shares Held After
13,817
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
116
Price
$456.87
Total Value
$53.00K
Shares Held After
14,509
% of Holdings
0.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
3,750
Price
$39.35
Total Value
$147.56K
Shares Held After
36,010
% of Holdings
9.4%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
65,832
Price
$39.35
Total Value
$2.59M
Shares Held After
394,996
% of Holdings
14.3%
Pliant Therapeutics, Inc. (PLRX)
Cummings Keith Lamont — Chief Financial Officer
Shares
24,002
Price
$1.28
Total Value
$30.72K
Shares Held After
297,214
% of Holdings
7.5%
Pliant Therapeutics, Inc. (PLRX)
Cheung Lily — Chief Human Resource Officer
Shares
7,534
Price
$1.28
Total Value
$9.64K
Shares Held After
44,847
% of Holdings
14.4%
Pliant Therapeutics, Inc. (PLRX)
Coulie Bernard — Director
Shares
89,375
Price
$1.28
Total Value
$114.40K
Shares Held After
505,601
% of Holdings
15.0%
Showing 201–250 of 1179 transactions (page 5 of 24)